232 related articles for article (PubMed ID: 9635544)
1. The use of pindolol to potentiate antidepressant medication.
Blier P; Bergeron R
J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
[TBL] [Abstract][Full Text] [Related]
2. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
Artigas F
Arch Gen Psychiatry; 1995 Nov; 52(11):969-71. PubMed ID: 7487345
[No Abstract] [Full Text] [Related]
3. [Interest of the use of pindolol in the treatment of depression: review].
Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Blier P; Bergeron R; de Montigny C
Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.
Nguyen KQ; Tohyama Y; Watanabe A; Hasegawa S; Skelin I; Diksic M
Neurochem Int; 2009; 54(3-4):161-71. PubMed ID: 19073228
[TBL] [Abstract][Full Text] [Related]
7. The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?
Kinney GG; Taber MT; Gribkoff VK
Mol Neurobiol; 2000 Jun; 21(3):137-52. PubMed ID: 11379796
[TBL] [Abstract][Full Text] [Related]
8. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
Gartside SE; Clifford EM; Cowen PJ; Sharp T
Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
[TBL] [Abstract][Full Text] [Related]
9. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.
Artigas F; Perez V; Alvarez E
Arch Gen Psychiatry; 1994 Mar; 51(3):248-51. PubMed ID: 8122960
[No Abstract] [Full Text] [Related]
10. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.
Artigas F; Romero L; de Montigny C; Blier P
Trends Neurosci; 1996 Sep; 19(9):378-83. PubMed ID: 8873352
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
Hjorth S; Auerbach SB
Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
[TBL] [Abstract][Full Text] [Related]
12. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?
Cremers TI; Wiersma LJ; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
Biol Psychiatry; 2001 Jul; 50(1):13-21. PubMed ID: 11457419
[TBL] [Abstract][Full Text] [Related]
13. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.
Blier P; Piñeyro G; el Mansari M; Bergeron R; de Montigny C
Ann N Y Acad Sci; 1998 Dec; 861():204-16. PubMed ID: 9928258
[TBL] [Abstract][Full Text] [Related]
14. Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans.
Martinez D; Hwang D; Mawlawi O; Slifstein M; Kent J; Simpson N; Parsey RV; Hashimoto T; Huang Y; Shinn A; Van Heertum R; Abi-Dargham A; Caltabiano S; Malizia A; Cowley H; Mann JJ; Laruelle M
Neuropsychopharmacology; 2001 Mar; 24(3):209-29. PubMed ID: 11166513
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
Moser PC; Sanger DJ
Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
[TBL] [Abstract][Full Text] [Related]
16. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
17. Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo.
Arborelius L; Linnér L; Wallsten C; Ahlenius S; Svensson TH
Psychopharmacology (Berl); 2000 Jul; 151(1):77-84. PubMed ID: 10958120
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
[TBL] [Abstract][Full Text] [Related]
19. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
Béïque JC; Blier P; de Montigny C; Debonnel G
Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
[TBL] [Abstract][Full Text] [Related]
20. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.
Berney A; Nishikawa M; Benkelfat C; Debonnel G; Gobbi G; Diksic M
Neurochem Int; 2008; 52(4-5):701-8. PubMed ID: 17928105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
